logo
Virginia emerges as key bellwether ahead of midterms

Virginia emerges as key bellwether ahead of midterms

Yahoo07-07-2025
Virginia's off-year elections are being viewed by both parties as a key bellwether heading into next year's midterms, as well as a potential indicator for how voters view President Trump.
Lt. Gov. Winsome Earle-Sears (R) and former Rep. Abigail Spanberger (D-Va.) will face off to become the first female governor of the state, while Democrats will seek to maintain and grow their majority in the House of Delegates.
The races could prove to be a litmus test for the first year of Trump's second administration as Republicans prepare to defend their majorities in Congress next year, especially as Virginia has a tendency to oscillate between the two parties in the race for governor.
'The Democrats want to look at this as a bellwether largely because they think they have an advantage here,' longtime Virginia political analyst Bob Holsworth said.
The nonpartisan Cook Political Report and Sabato's Crystal Ball each rate the gubernatorial contest as 'lean Democratic.'
A Roanoke College survey released in May showed Spanberger with a wide 43 percent to 26 percent lead over Earle-Sears, with 28 percent of voters saying they were undecided. However, another May poll released by the business group Virginia FREE showed Spanberger leading by 4 percentage points.
Spanberger also holds a fundraising lead over Earle-Sears. According to the Virginia Public Access Project, Spanberger raised $6.5 million, while Earle-Sears brought in $3.5 million; Spanberger currently has more than $14 million in the bank, while Earle-Sears has just less than $3 million.
Spanberger, a former intelligence officer, has a history as a formidable candidate, having unseated former Rep. Dave Brat (R) in the state's highly competitive 7th Congressional District and gone on to win reelection twice. Additionally, she has touted herself as a moderate Democrat, pointing to her work across the aisle while serving in the House.
While Spanberger has touted a number of kitchen table issues including affordability, investing in schools and community safety, she also often points to federal government job cuts made under Trump's Department of Government Efficiency (DOGE). The cuts have had a unique impact on Virginia, given the federal government's close proximity to the state.
'Virginia is home to more than 320,000 federal employees,' Spanberger said in an interview with The Hill. 'I will never miss an opportunity to make sure the president understands that the haphazard DOGE effort has been deeply, deeply detrimental to Virginians, to their families, to our economy, and that the havoc it has wreaked across our commonwealth is so significant.'
'As a former national security professional, I have dire concerns about what the future looks like,' she said, referring to laid-off government employees with 'institutional understanding and historical references.'
Earle-Sears, who is originally from Jamaica, has a background as a Marine Corps veteran and business owner. She served in the House of Delegates from 2002-04, ending her tenure when she challenged Rep. Bobby Scott (D-Va.) in the state's 3rd Congressional District in 2004. In 2021, she became Virginia's first female lieutenant governor, winning alongside Gov. Glenn Youngkin (R) and Attorney General Jason Miyares (R).
Earle-Sears has leaned into her work in the Youngkin administration in making her case to the commonwealth's voters, particularly on job creation.
'[Voters] all pretty much say they want what we are doing in Virginia to continue, and my opponent's problem is she was never a part of creating this great economy that we have, bringing all these jobs to Virginia,' Earle-Sears told The Hill in an interview.
In the wake of the DOGE cuts, Youngkin and Earle-Sears have touted the administration's 'Virginia Has Jobs' initiative, which includes 250,000 open jobs in the state. A 'support resource bundle' would also be available to federal workers looking for work.
Democrats have attacked Earle-Sears over her response to the impact of DOGE cuts on the state, however, pointing to remarks she made earlier this year in which she touted the state's jobs initiative and said losing a job is 'not unusual.'
'I have lost a job, and in any room that this has been brought up, I ask the people: 'How many of you have ever lost a job?'' Earle-Sears told The Hill last month, referring to remarks from earlier this year. 'I raised my hand, along with them. And I got to tell you, we don't want people to, of course, not have jobs, and that's why we have been so successful in creating over 270,000 of them.'
However, Republicans are still voicing concerns about Earle-Sears's chances in November.
Veteran GOP strategist and senior adviser to Trump's 2024 presidential campaign Chris LaCivita called her staff 'amateurs' in a post on the social platform X in May, while one Virginia Republican strategist called this year's cycle 'a hard hill to climb' for Republicans.
'The money disadvantage is massive, and that's a problem,' the Virginia GOP strategist said. 'That's the challenge beyond structure: the resource piece, and running really good campaigns.'
The strategist noted that in addition to touting her work in Youngkin's administration, Earle-Sears could draw on issues that have played well for Republicans nationally.
'There are encouraging signs,' the strategist said. 'Obviously the president's approval rating, stability around the world, stability on trade policy. There are the conditions for the national environment to be solid, and yet still it is a challenging state to compete in simply because of the makeup of the state and, historically, just with the party in power, it makes it difficult to [hold onto the governorship].'
During Trump's first administration in 2017, Democrats saw victories in the gubernatorial, lieutenant gubernatorial and state attorney general races. Democrats did not win a majority in the House of Delegates that year, but they narrowed the GOP majority to one seat.
Two years later, in 2019, Virginia Democrats gained control of the House of Delegates and the state Senate, giving the party control of both legislative chambers and the governor's mansion for the first time since 1994.
In 2021, when former President Biden was in the White House, Republicans hit back in the state's off-year elections, when they won back control of the House of Delegates and Youngkin won the gubernatorial contest.
When asked about whether Trump's presence in the White House will impact the gubernatorial race, Earle-Sears said the campaign is about her and Spanberger.
'This race is about Abigail Spanberger and me and the commonsense ideas that I stand for,' Earle-Sears said. 'People can differentiate and make that distinction.'
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US Fed independence under threat, say economists, but no one expects a July rate cut- Reuters poll
US Fed independence under threat, say economists, but no one expects a July rate cut- Reuters poll

Yahoo

time28 minutes ago

  • Yahoo

US Fed independence under threat, say economists, but no one expects a July rate cut- Reuters poll

By Indradip Ghosh BENGALURU -The U.S. Federal Reserve's independence is under threat from mounting political interference, according to a clear majority of economists polled by Reuters, although no one expects a July interest rate cut despite a recent divergence in views among policymakers. President Donald Trump has made it almost a daily routine to personally attack Fed Chair Jerome Powell over the central bank's stance of holding rates due to tariff-related risks of higher inflation. A recent jump in inflation suggests businesses are now passing some of the tariffs onto consumers. Most Federal Market Open Committee members favor holding rates steady, but a few, including Governor Chris Waller and Trump appointee Fed Vice Chair for Supervision Michelle Bowman, have recently advocated a reduction as soon as July 30. Powell's term is set to expire in May 2026. Waller last week said he would accept the job as the bank's head if he was offered it by Trump. An over 70% majority of economists in the July 17-23 Reuters poll who answered an additional question, 36 of 50, said they were worried about the Fed's independence from political influence, including 10 who said they were very concerned. The remaining 14 said they were not. "I am more worried about the Fed's independence than I was a few months ago, and the main reason for that is the recent behaviour of Governors Bowman and Waller. It's very notable they are diverging from the consensus," said Philip Marey, senior U.S. strategist at Rabobank. "This year is still Powell's Fed. The current Fed is very cautious and wants to wait for the data and go only when they're sure ... It is kind of a policy paralysis at the moment and I don't think that will change as long as Powell has some grip on the FOMC," he added. All 105 economists said the Fed, which last cut its key interest rate to 4.25%-4.50% in December, will hold rates again at the conclusion of its July 29-30 meeting. Most respondents maintained their rate outlook or expected fewer reductions compared with a poll taken last month. A slight 53% majority of economists, 56 of 105, forecast a cut in September, in line with market pricing. But with less than half the year remaining, a clear consensus on where rates would be by end-2025 remains elusive. Economists are waiting for clarity on trade policies as a deadline for Trump's so-called "reciprocal" tariffs first announced in April approaches. That deadline of August 1 is itself an extension from a previous July 9 deadline. "Tariffs could affect things both in terms of higher inflation (and) it could slow the economy. The Fed doesn't know exactly what that mix is going to be and that's reason enough to wait," said Jonathan Millar, senior U.S. economist at Barclays. Just under two-thirds of forecasters expect one or two rate cuts this year, with nearly a fifth expecting no cuts at all. Interest rate futures are pricing in two reductions. The Fed will cut twice next year, poll medians showed. "We've had a very substantial easing of policy over the last few months just from the fact the dollar has weakened and improvements in equity markets. It's not as if things are really screaming out for a rate cut," Millar said. Inflation forecasts were broadly unchanged from last month, with economists forecasting it will average above the Fed's 2% target through at least 2027. The recent passage of Trump's signature spending bill, expected to add $3.4 trillion to an already enormous $36.2 trillion debt pile, poses a further risk of reigniting price pressures. The economy, which contracted 0.5% last quarter, is forecast to grow just 1.5% this year, a sharp slowdown from 2.8% in 2024. Next year, it was expected to expand 1.6%, a view that has remained steady since May. (Other stories from the Reuters global economic poll) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Amprion Announces Strategic Growth Initiatives, Expanding Access to Breakthrough SAAmplify Test
Amprion Announces Strategic Growth Initiatives, Expanding Access to Breakthrough SAAmplify Test

Yahoo

time28 minutes ago

  • Yahoo

Amprion Announces Strategic Growth Initiatives, Expanding Access to Breakthrough SAAmplify Test

Company Launches New Website, Scales Test Access Alongside Mayo Clinic, & Looks to Expand International Presence SAN DIEGO, July 23, 2025--(BUSINESS WIRE)--Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, has announced several strategic growth initiatives to broaden access to its SAAmplify-ɑSYN test. These initiatives include a comprehensive website refresh, expanded test availability via Mayo Clinic's network of hospitals and clinical sites, and ongoing preparations for international expansion. As part of its continuing growth and commitment to advancing early and accurate diagnosis, Amprion will showcase its latest developments and momentum at the Alzheimer's Association International Conference (AAIC), July 27-31, 2025, in Toronto, Canada. Attendees can connect with the Amprion team at booth #616. Following its recent collaboration with Mayo Clinic Laboratories, Amprion launched a newly redesigned website to meet the growing demand for its SAAmplify-ɑSYN test, which aids in the diagnosis of synucleinopathies. The breakthrough test can detect the presence of aggregates of alpha-synuclein protein, the underlying pathology of Parkinson's disease (PD), Lewy body dementia (LBD), multiple system atrophy (MSA), and Alzheimer's disease with Lewy bodies (AD + DLB), in cerebrospinal fluid. Launched earlier this month, the updated website is designed to provide patients, clinicians, and industry leaders with streamlined access to Amprion's latest research, information, and more. "As awareness and demand for our SAAmplify-ɑSYN test grow, we're working to ensure clinicians, researchers, and patients have better access to the tools and information they need," said Dr. Russ Lebovitz, CEO and co-founder of Amprion. "Our refreshed website and expanding partnerships are steps toward that goal, and we look forward to connecting with the global neuroscience community at AAIC." Due to this surge in awareness, Amprion is actively exploring international expansion opportunities, with plans to bring its test to European and global markets. Initial announcements regarding country-specific launch strategies are expected in Q4 2025. For more information or to schedule a meeting with Amprion at AAIC 2025, please visit About SAAmplify-ɑSYN (formerly SYNTap®) Amprion's SAAmplify-ɑSYN test is a first-in-class-qualitative Laboratory Developed Test (LDT) and the only seed amplification assay available to aid the diagnosis of synucleinopathies such as Parkinson's disease (PD), Lewy body dementia (LBD/DLB), and Alzheimer's disease (AD) with Lewy body co-pathology. The U.S. Food and Drug Administration (FDA) granted Amprion a Breakthrough Device Designation in 2019 for use of the test as an aid in the diagnosis of PD. The test became commercially available in the US in 2021. About Amprion Amprion is the global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing. Amprion's intellectual property surrounding SAA methodology extends to research, drug development, and commercialization. SAAmplify-ɑSYN (formerly SYNTap®) is the only seed amplification assay available to aid the diagnosis of synucleinopathies such as Parkinson's disease, Lewy body dementia, and Alzheimer's disease with Lewy body co-pathology. Amprion is also accelerating precision medicine for neurodegenerative disorders by helping biopharma partners identify new drug candidates and underlying pathologies. Learn more at or find us on LinkedIn. View source version on Contacts Media Contacts Liz RobinsonCG Lifelrobinson@ Karen SharmaCG Lifeksharma@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Boston Scientific trumps top and bottom-line forecasts, issues upbeat 2025 guide
Boston Scientific trumps top and bottom-line forecasts, issues upbeat 2025 guide

Yahoo

time28 minutes ago

  • Yahoo

Boston Scientific trumps top and bottom-line forecasts, issues upbeat 2025 guide

-- Boston Scientific (NYSE:BSX) posted second-quarter results that topped expectations, driven by strong organic growth and solid performance across key regions. Adjusted EPS came in at $0.75, beating the $0.73 consensus. Revenue rose to $5.06 billion, up 22.8% year-over-year, exceeding the $4.89 billion forecast. On an organic basis, sales increased 17.4% year-over-year. "This was another excellent quarter — marked by exceptional top-line performance — that delivered margin expansion and prioritized investment for future growth," said Mike Mahoney, chairman and CEO of Boston Scientific. The company saw strong double-digit growth in the U.S. and Asia-Pacific of 30.7% and 18%, respectively, while EMEA and Latin America posted more modest gains. Emerging markets also contributed with healthy growth. For the third quarter, it guided to EPS of $0.70 to $0.72, compared to expectations of $0.70. Looking further ahead, Boston Scientific expects full-year 2025 EPS in the range of $2.95 to $2.99, above the $2.92 consensus. Related articles Boston Scientific trumps top and bottom-line forecasts, issues upbeat 2025 guide These Under-the-Radar Stocks Offer Better Risk-Reward Ratio Than Nvidia After soaring 149%, this stock is back in our AI's favor - & already +25% in July

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store